Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshiki Watanabe

Showing results (191-200 of 217) with videos related to

Pageof 22
Sort By:
Blood|June 16, 2005
Dual targeting of transformed and untransformed HTLV-1-infected T cells by DHMEQ, a potent and selective inhibitor of NF-kappaB, as a strategy for chemoprevention and therapy of adult T-cell leukemiaMariko Watanabe, Takeo Ohsugi, Momoko Shoda, et al.
Molecular Cancer|June 7, 2021
Germinal epimutation of Fragile Histidine Triad (FHIT) gene is associated with progression to acute and chronic adult T-cell leukemia diseasesMarcia Bellon, Izabela Bialuk, Veronica Galli, et al.
The Journal of Dermatology|August 23, 2025
An Open-Label, Multicenter, Phase II Study of Bexarotene in Patients With Adult T-Cell Leukemia/LymphomaKentaro Yonekura, Ikko Muto, Motoi Takenaka, et al.
Blood|May 8, 2010
Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in JapanMasako Iwanaga, Toshiki Watanabe, Atae Utsunomiya, et al.
The Lancet. Microbe|November 10, 2025
A viral clonality evenness score to predict progression to adult T-cell leukaemia in asymptomatic carriers of human T-lymphotropic virus type 1 in Japan: a retrospective longitudinal cohort studySnehal Dilip Karpe, Maria Artesi, Jérôme Wayet, et al.
Frontiers in Medicine|April 28, 2022
Health-Related Quality of Life Evaluation Using the Short Form-36 in Patients With Human T-Lymphotropic Virus Type 1-Associated MyelopathyMiyuna Kimura, Junji Yamauchi, Tomoo Sato, et al.
Cell Reports|November 21, 2019
Targeting Excessive EZH1 and EZH2 Activities for Abnormal Histone Methylation and Transcription Network in Malignant LymphomasMakoto Yamagishi, Makoto Hori, Dai Fujikawa, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 13, 2020
Mortality and risk of progression to adult T cell leukemia/lymphoma in HTLV-1-associated myelopathy/tropical spastic paraparesisMisako Nagasaka, Makoto Yamagishi, Naoko Yagishita, et al.
International Journal of Hematology|July 30, 2020
A high-throughput detection method for the clonality of Human T-cell leukemia virus type-1-infected cells in vivoMasumichi Saito, Hiroo Hasegawa, Shunsuke Yamauchi, et al.
Nature|February 21, 2024
Mechanisms of action and resistance in histone methylation-targeted therapyMakoto Yamagishi, Yuta Kuze, Seiichiro Kobayashi, et al.
Pageof 22

Showing results (191-200 of 217) with videos related to

Sort By:
Pageof 22
Blood|June 16, 2005
Dual targeting of transformed and untransformed HTLV-1-infected T cells by DHMEQ, a potent and selective inhibitor of NF-kappaB, as a strategy for chemoprevention and therapy of adult T-cell leukemiaMariko Watanabe, Takeo Ohsugi, Momoko Shoda, et al.
Molecular Cancer|June 7, 2021
Germinal epimutation of Fragile Histidine Triad (FHIT) gene is associated with progression to acute and chronic adult T-cell leukemia diseasesMarcia Bellon, Izabela Bialuk, Veronica Galli, et al.
The Journal of Dermatology|August 23, 2025
An Open-Label, Multicenter, Phase II Study of Bexarotene in Patients With Adult T-Cell Leukemia/LymphomaKentaro Yonekura, Ikko Muto, Motoi Takenaka, et al.
Blood|May 8, 2010
Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in JapanMasako Iwanaga, Toshiki Watanabe, Atae Utsunomiya, et al.
The Lancet. Microbe|November 10, 2025
A viral clonality evenness score to predict progression to adult T-cell leukaemia in asymptomatic carriers of human T-lymphotropic virus type 1 in Japan: a retrospective longitudinal cohort studySnehal Dilip Karpe, Maria Artesi, Jérôme Wayet, et al.
Frontiers in Medicine|April 28, 2022
Health-Related Quality of Life Evaluation Using the Short Form-36 in Patients With Human T-Lymphotropic Virus Type 1-Associated MyelopathyMiyuna Kimura, Junji Yamauchi, Tomoo Sato, et al.
Cell Reports|November 21, 2019
Targeting Excessive EZH1 and EZH2 Activities for Abnormal Histone Methylation and Transcription Network in Malignant LymphomasMakoto Yamagishi, Makoto Hori, Dai Fujikawa, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 13, 2020
Mortality and risk of progression to adult T cell leukemia/lymphoma in HTLV-1-associated myelopathy/tropical spastic paraparesisMisako Nagasaka, Makoto Yamagishi, Naoko Yagishita, et al.
International Journal of Hematology|July 30, 2020
A high-throughput detection method for the clonality of Human T-cell leukemia virus type-1-infected cells in vivoMasumichi Saito, Hiroo Hasegawa, Shunsuke Yamauchi, et al.
Nature|February 21, 2024
Mechanisms of action and resistance in histone methylation-targeted therapyMakoto Yamagishi, Yuta Kuze, Seiichiro Kobayashi, et al.
Pageof 22